# Ember LifeSciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ember-lifesciences

- Industry: Healthcare IT
- Headquarters: Westlake Village, US
- Website: www.emberlifesciences.com
- Total disclosed funding: $49M
- Latest round: Series A (Aug 20, 2026)
- Investors on record: 4

## About

Based in the U.S., Ember LifeSciences operates as a healthcare technology provider specializing in cold chain logistics solutions for the safe transport of temperature-sensitive medicines and vaccines. The company leverages proprietary temperature control and cloud-connected technologies to improve delivery reliability, reduce waste, and enhance patient outcomes.Based in California, U.S. and founded in 2022, Ember LifeSciences, Inc., founded by Clay Alexander, provides temperature-controlled logistics solutions for the pharmaceutical and biopharma industry. The company was launched to extend Ember’s proprietary thermal management technology into healthcare, focusing on improving the global distribution of life-saving medicines. In May 2026, Ember LifeSciences raised USD 10.5 million in series A funding co-led by Amgen Ventures and TDF Ventures. The round was part of a larger USD 27 million series A funding.The company’s core offering includes the Ember Cube, a self-refrigerated, cloud-based shipping container designed for transporting temperature-sensitive pharmaceuticals with real-time tracking and monitoring capabilities. It also develops reusable, modular cold chain solutions that ensure temperature integrity, reduce reliance on single-use packaging, and support scalable logistics operations.Ember LifeSciences primarily generates revenue through the sale and deployment of its proprietary cold chain shipping hardware, including the Ember Cube and related logistics solutions. Additionally, it derives value from enterprise partnerships with pharmaceutical companies and distributors by providing technology-enabled logistics services and connected monitoring platforms.

## Funding rounds

- Series A, Aug 20, 2026, $32M — Amgen Ventures, TDF Ventures
- Series A, Dec 16, 2025, $17M — Cardinal Health, Carrier Ventures

## Investors

- Cardinal Health — Series A
- Carrier Ventures (https://capitalatlas.ai/funds/carrier-ventures) — Series A
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series A
- TDF Ventures (https://capitalatlas.ai/funds/tdf-ventures) — Series A